Altogether, these findings support the rationale behind the potential role of CGRP in both entities (Figure 2), migraine and depression; though further studies are required, this could provide an innovative approach for patients that could benefit from undergoing treatment targeting CGRP. Here, CALCA is linked to depressive symptom measurement.